<ѻýҕl>Upfront Systemic Therapy, Deferred Surgery Pass Muster in Advanced Kidney Cancerѻýҕl> Two studies suggest no harm from deferred cytoreduction, potential benefits of immunotherapy May 02, 2023
<ѻýҕl>CAR T-Cell Therapy Shows Promise in Advanced Kidney Cancerѻýҕl> ORR of 30% in patients with CD70-positive disease using off-the-shelf, allogeneic product Apr 19, 2023
<ѻýҕl>Post-Immunotherapy Combo Promising in Advanced RCCѻýҕl> Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
<ѻýҕl>Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancersѻýҕl> ZIRCON trial meets sensitivity and specificity targets Mar 13, 2023
<ѻýҕl>Combo Falters in Papillary Renal Cancer, but Some Promise in MET-Driven Subsetѻýҕl> Over 50% of patients with advanced MET-driven tumors responded to savolitinib plus durvalumab Feb 24, 2023
<ѻýҕl>ICI/TKI Combo Maintains Survival Benefit in Advanced RCCѻýҕl> Updated trial data show nivolumab/cabozantinib doublet "is getting better with age" Feb 20, 2023
<ѻýҕl>Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumorsѻýҕl> Approach in small ongoing trial resulted in reduction in tumor size and complexity Dec 02, 2022
<ѻýҕl>Allogeneic CAR T-Cell Therapy Shows Early Promise in Kidney Cancerѻýҕl> CTX130 yields sustained complete response in one patient with relapsed/refractory disease Nov 15, 2022
<ѻýҕl>Role of Cytoreductive Nephrectomy Unclear for Dedifferentiated Kidney Cancerѻýҕl> Thirteen-month survival gain falls short of statistical significance in observational study Nov 10, 2022
<ѻýҕl>Immune Stimulator May Enhance Targeted Therapy's Activity in Metastatic RCCѻýҕl> Numerical advantage in median survival, response rate, durability with dendritic-cell agent Nov 09, 2022
<ѻýҕl>Immunotherapy Doublet Shows Promise for Nonsurgical Control of Small Kidney Cancersѻýҕl> Nivolumab/ipilimumab achieves 1-year PFS of 100% in unresectable T1N0M0 tumors Nov 07, 2022
<ѻýҕl>Probiotic May Rev Up Response to Immunotherapy in Advanced Kidney Cancerѻýҕl> Dramatic slowing of disease progression, prolonged responses with microbiome modulator Nov 06, 2022
<ѻýҕl>Triplet in First-Line Kidney Cancer Thwarts Disease Progressionѻýҕl> Randomized study shows "clinically meaningful" PFS improvement over dual immunotherapy alone Sep 13, 2022
<ѻýҕl>Three Adjuvant Immunotherapy Trials Flop in Renal Cell Carcinomaѻýҕl> Studies appear to contradict benefit previously shown with pembrolizumab in this setting Sep 12, 2022
<ѻýҕl>Fewer Complications With Robotic Nephrectomy in Complex Kidney Tumorsѻýҕl> However, trial comparing robotic and open surgery was stopped early due to low enrollment Jul 06, 2022
<ѻýҕl>Oral Retinoid May Ease Painful Skin Reactions to Anticancer Therapyѻýҕl> Preliminary data on acitretin therapy are promising May 11, 2022
<ѻýҕl>Check Troponin in RCC Patients Before Checkpoint-VEGFR Inhibitor Comboѻýҕl> In JAVELIN Renal 101, those with high levels had more heart events with avelumab-axitinib Mar 05, 2022
<ѻýҕl>FDA OKs PD-1 Inhibitor for Adjuvant Treatment of Kidney Cancerѻýҕl> Key trial showed 32% reduction in risk of recurrence with pembrolizumab Nov 18, 2021
<ѻýҕl>Cabozantinib Shows Activity Against RCC Brain Metastasesѻýҕl> Retrospective study reported intracranial responses in about one half of patients Oct 22, 2021
<ѻýҕl>'A Quantum Leap Forward': Potential New Standard in High-Risk RCCѻýҕl> Adjuvant immunotherapy led to 32% reduction in the risk of recurrence, positive trend in OS Jun 03, 2021
<ѻýҕl>How Did a Patient Survive a Decade With Metastatic RCC?ѻýҕl> Surgery had beneficial role May 17, 2021
<ѻýҕl>A CLEAR Upfront Winner in Advanced RCC?ѻýҕl> Pembrolizumab-lenvatinib makes splash with longest PFS benefit in RCC recorded to date Feb 14, 2021
<ѻýҕl>Practice-Changing Trial in Metastatic Papillary RCCѻýҕl> Cabozantinib improved PFS, response rates over sunitinib Feb 14, 2021
<ѻýҕl>Another First-Line Combo Succeeds in Advanced RCCѻýҕl> Third immunotherapy plus TKI combination tops sunitinib Sep 19, 2020
<ѻýҕl>Olympic Ice Dancer's Renal Cell Carcinomaѻýҕl> Maia Shibutani is "embracing the moment" and raising money for healthcare workers Sep 10, 2020
<ѻýҕl>Cancer Immunotherapy Tied to Severe COVID-19 Outcomesѻýҕl> Nearly threefold increased risk of hospitalization, severe respiratory illness Jun 25, 2020
<ѻýҕl>6-Week Keytruda Safe, Effective in Melanomaѻýҕl> Schedule gets FDA approval for all adult indications Apr 30, 2020
<ѻýҕl>DOAC Works in Cancer-Related VTE, No Tradeoff in Bleedsѻýҕl> Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
<ѻýҕl>Are Low-Density Incidental Renal Masses Being Misdiagnosed?ѻýҕl> New study raises concerns about criteria for benign cysts vs aggressive renal cancer Dec 23, 2019
<ѻýҕl>Metastatic Renal Cell Carcinoma: Watch for Brain Metsѻýҕl> Present in roughly 5% of patients, survival worse in patients with larger or more lesions Nov 18, 2019
<ѻýҕl>Long-Term Surveillance Safe for Small Renal Tumorsѻýҕl> Two cases of metastasis, one cancer death after almost 5 years of follow-up Jun 13, 2019
<ѻýҕl>Surgery Delay OK for Most With Renal Cell Carcinomaѻýҕl> Two studies add support for active surveillance for small tumors May 08, 2019
<ѻýҕl>Do Keloids Convey a Higher Cancer Risk?ѻýҕl> Taiwanese researchers show association between raised scars and cancers Mar 03, 2019
<ѻýҕl>No Survival Bump Yet with Tivozanib for RCCѻýҕl> Selected studies on kidney cancer from the Genitourinary Cancers Symposium Feb 18, 2019
<ѻýҕl>Will Biomarkers Eventually Replace Physicians?ѻýҕl> Milton Packer imagines the end of nonprocedural medicine as we know it Jan 16, 2019
<ѻýҕl>Kidney Stones Tied to Renal Carcinomaѻýҕl> But more research is needed to unravel mechanisms behind the relationships, study authors say Dec 20, 2018
<ѻýҕl>SABR Equally Effective in RCC Patients With One or Both Kidneysѻýҕl> Minimal side effects reported with high-dose treatment Oct 23, 2018
<ѻýҕl>Combination Slows Advanced RCCѻýҕl> Avelumab-axitinib beneficial, irrespective of PD-L1 status Oct 23, 2018
<ѻýҕl>Morning Break: Human Side of Addiction; Eyeing Da Vinci's Genius; No CV Indication for Ilarisѻýҕl> Health news and commentary from around the Web gathered by the ѻýҕl staff Oct 19, 2018
<ѻýҕl>Many with Metastatic Kidney Cancer Can Skip Surgeryѻýҕl> Overall survival with single-agent sunitinib better than with resection Jun 04, 2018